We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
Cap. Flow
-$1.03B
Cap. Flow %
-2.85%
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Financials 14.92%
3 Technology 12.39%
4 Consumer Discretionary 8.32%
5 Consumer Staples 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGA icon
2026
Magna International
MGA
$17.4B
$1.52K ﹤0.01%
27
CIVB icon
2027
Civista Bancshares
CIVB
$571M
$1.5K ﹤0.01%
68
+16
+31% +$361
INZY
2028
DELISTED
Inozyme Pharma
INZY
$1.45K ﹤0.01%
1,381
-152
-10% -$266
AMSC icon
2029
American Superconductor
AMSC
$1.32B
$1.44K ﹤0.01%
391
ACAD icon
2030
Acadia Pharmaceuticals
ACAD
$4.74B
$1.42K ﹤0.01%
89
-50
-36% -$782
AEVA
2031
Aeva Technologies
AEVA
$1.02B
$1.39K ﹤0.01%
205
-226
-52% -$1.98K
HBT icon
2032
HBT Financial
HBT
$1.33B
$1.39K ﹤0.01%
+71
New +$1.4K
STLA icon
2033
Stellantis
STLA
$15.3B
$1.36K ﹤0.01%
96
-11
-10% -$153
SPRB
2034
Spruce Biosciences
SPRB
$154M
$1.32K ﹤0.01%
16
+1
+7% +$84
HVT icon
2035
Haverty Furniture Companies
HVT
$434M
$1.32K ﹤0.01%
+44
New +$1.29K
EVLV icon
2036
Evolv Technologies
EVLV
$935M
$1.31K ﹤0.01%
+506
New +$1.49K
ONCT
2037
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.3K ﹤0.01%
65
-7
-10% -$139
HDSN
2038
Hudson Technologies
HDSN
$227M
$1.28K ﹤0.01%
+127
New +$1.24K
DICE
2039
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$1.28K ﹤0.01%
+41
New +$1.34K
REPX icon
2040
Riley Exploration Permian
REPX
$964M
$1.24K ﹤0.01%
42
-59
-58% -$1.68K
MTEM
2041
DELISTED
Molecular Templates, Inc.
MTEM
$1.24K ﹤0.01%
251
+65
+35% +$538
APEI icon
2042
American Public Education
APEI
$822M
$1.23K ﹤0.01%
100
-26
-21% -$322
CALC icon
2043
CalciMedica
CALC
$13.7M
$1.19K ﹤0.01%
34
EXTR icon
2044
Extreme Networks
EXTR
$2.9B
$1.15K ﹤0.01%
+63
New +$1.1K
IMDX
2045
Insight Molecular Diagnostics
IMDX
$137M
$1.15K ﹤0.01%
179
+58
+48% +$639
FSBW icon
2046
FS Bancorp
FSBW
$340M
$1.14K ﹤0.01%
+34
New +$1.06K
GOGO icon
2047
Gogo Inc
GOGO
$355M
$1.14K ﹤0.01%
77
-196,677
-100% -$2.84M
MRTX
2048
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.13K ﹤0.01%
25
-260,245
-100% -$16.8M
RAD
2049
DELISTED
Rite Aid Corporation
RAD
$1.13K ﹤0.01%
339
-460
-58% -$2.19K
MACK
2050
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.03K ﹤0.01%
90
-1
-1% -$8

Similar funds

Federated Hermes's Q4 2022 Portfolio in Review

As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

  • Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
  • Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
  • Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
  • Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
  • Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
  • Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
  • Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.